Login:
 
Savill P. PPIs with aspirin in older patients lowers risk of major bleeds. Practitioner 2017;261(1806):5

PPIs with aspirin in older patients lowers risk of major bleeds

28 Jul 2017Registered users

The current recommendation for patients suffering ischaemic vascular events is for lifelong antiplatelet treatment based on trial data mainly in patients under the age of 75. A UK prospective population-based cohort study assessed the risk, time course, and outcomes of bleeding on antiplatelet treatment for the secondary prevention of cardiovascular disease in patients of all ages. The Oxford Vascular Study (OXVASC) covers 92,728 patients registered with 100 GPs from nine practices in Oxfordshire.

Registered usersThis article can only be accessed if you are a registered user of thepractitioner.co.uk or a subscriber to The Practitioner.